An artificial intelligence-based prostate cancer management platform recently made its official debut in clinical settings with patients at a renowned U.S. research hospital. 

The Unfold AI platform—a product of AI healthcare company Avenda Health—is reportedly already being used by several physicians at the hospital. The recently FDA-cleared program merges patient-specific information from prostate imaging, biopsies and pathology together, resulting in a deep learning algorithm that creates an AI-generated 3D map of patients’ cancer. This map allows providers to get a precise view…